Skip to content

Clinical trials

Hepatorenal Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatorenal Syndrome Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20101
20111
20142
20151
20161
20201
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Recruiting2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mallinckrodt3
Azienda Ospedaliera di Padova1
Cumberland Pharmaceuticals1
La Jolla Pharmaceutical Company1
Lahey Clinic1
Lenar Yessayan1
Massachusetts General Hospital1
Methodist Health System1
Ocelot Bio, Inc1
Patrick Northup, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatorenal Syndrome16
Acute Kidney Injury6
Fibrosis5
Renal Insufficiency4
Ascites3
Liver Cirrhosis3
Hepatitis, Alcoholic1
Hypertension, Portal1
Kidney Cortex Necrosis1
Liver Diseases1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.